HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics AG (NBRV), sold 31,069 shares at $11.03 ($343K) on 2017-04-28, disclosed to the SEC on 2017-04-28.
Open-market sale of $343k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 709 | $8K | 2.3% |
| 2 | $11.00 | 100 | $1K | 0.3% |
| 3 | $11.03 | 15,130 | $167K | 48.7% |
| 4 | $11.03 | 15,130 | $167K | 48.7% |
| Total | $11.03 avg | 31,069 | $343K | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |